Analyst firms · Morgan Stanley · NXPI
Morgan Stanley NXPI price target and rating history
NXP Semiconductors N.V. (NXPI) · Technology
Morgan Stanley rates NXP Semiconductors N.V. (NXPI) Overweight with a $257 price target, as of its latest action on Feb 12, 2025. It has published 5 rating actions on NXPI since August 2021, including 1 upgrade and 0 downgrades. Across 6 firms with a NXPI price target in the last 12 months, the median target is $247.50.
- Current rating
- Overweight
- Price target
- $257
- Median target, all firms
- $247.50
- Actions on NXPI
- 5
Morgan Stanley price target on NXPI
Every Morgan Stanley rating on NXPI
- Feb 12, 2025
- Feb 2, 2022
- Dec 15, 2021
- Nov 3, 2021
- Aug 4, 2021
How other firms rate NXPI
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Citigroup | Neutral | $260 | Oct 8, 2026 |
| UBS | Neutral | $270 | Aug 3, 2026 |
| Cantor Fitzgerald | Overweight | $380 | May 13, 2026 |
| Wells Fargo | Equal Weight | $235 | Apr 20, 2026 |
| Mizuho | Underperform | $188 | Apr 17, 2026 |
| BofA Securities | Neutral | $230 | Apr 13, 2026 |
Questions about Morgan Stanley and NXPI
- What is Morgan Stanley's price target for NXPI?
- Morgan Stanley's latest stated price target for NXP Semiconductors N.V. (NXPI) is $257, from its action on Feb 12, 2025.
- What is Morgan Stanley's rating on NXPI?
- Morgan Stanley rates NXPI Overweight, a bullish rating, as of Feb 12, 2025.
- When did Morgan Stanley last change its view on NXPI?
- On Feb 12, 2025, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $231 to $257.
- How does Morgan Stanley's NXPI target compare with other analysts?
- Across 6 firms with a NXPI price target in the last 12 months, the median target is $247.50.
More NXPI rating histories
All Morgan Stanley ratingsNXPI news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.